What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Mesothelioma, Pathology, Lung cancer, Internal medicine and Cancer research.
The various areas that he examines in his Mesothelioma study include Virus, Pleural disease and Surgery.
His Pathology research integrates issues from Lung and Receiver operating characteristic.
His Lung cancer study combines topics in areas such as Stage, Radiation therapy and Adenocarcinoma.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Oncology.
His Cancer research study also includes fields such as
- microRNA and related Oncogene,
- Gene which is related to area like Molecular biology.
His most cited work include:
- Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
- MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib (1330 citations)
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. (1326 citations)
What are the main themes of his work throughout his whole career to date?
Harvey I. Pass mainly investigates Mesothelioma, Cancer research, Lung cancer, Pathology and Internal medicine.
His research investigates the connection between Mesothelioma and topics such as Surgery that intersect with problems in Sarcoma.
His Cancer research course of study focuses on Cell culture and Molecular biology.
His studies in Lung cancer integrate themes in fields like Stage, Clinical trial, Radiology and Adenocarcinoma.
His study in Pathology is interdisciplinary in nature, drawing from both Osteopontin and Lung.
His research in Internal medicine focuses on subjects like Oncology, which are connected to Radiation therapy.
He most often published in these fields:
- Mesothelioma (27.70%)
- Cancer research (26.39%)
- Lung cancer (24.14%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (26.39%)
- Lung cancer (24.14%)
- Mesothelioma (27.70%)
In recent papers he was focusing on the following fields of study:
Harvey I. Pass mostly deals with Cancer research, Lung cancer, Mesothelioma, Cancer and Internal medicine.
Harvey I. Pass has included themes like DNA methylation, Carcinogenesis, microRNA, Pleural mesothelioma and Adenocarcinoma in his Cancer research study.
His study focuses on the intersection of Lung cancer and fields such as Clinical trial with connections in the field of Family medicine, Extrapleural Pneumonectomy and Disease.
His study on Mesothelioma also encompasses disciplines like
- MEDLINE together with Metastasectomy,
- Radiation therapy most often made with reference to General surgery.
The concepts of his Cancer study are interwoven with issues in Precision medicine, Medical physics and Gene.
His work deals with themes such as Gastroenterology and Oncology, which intersect with Internal medicine.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma (180 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His scientific interests lie mostly in Lung cancer, Cancer research, Cancer, Mesothelioma and Clinical trial.
His Lung cancer research incorporates themes from Microbiome, Radiology and Lung.
His research in Lung intersects with topics in Exome sequencing, Neoplastic transformation, Pathology, Atypical adenomatous hyperplasia and Adenocarcinoma in situ.
His work carried out in the field of Cancer research brings together such families of science as DNA methylation, Oncogene and Transcription factor, Gene, microRNA.
His Cancer study deals with the bigger picture of Internal medicine.
His research on Mesothelioma focuses in particular on BAP1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
